Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 301

HealthWatch finds time for $20m Yiling investment

Yiling Pharmaceuticals has paid $15m for a 23% stake in HealthWatch and another $5m for the Chinese distribution rights to its health-monitoring garment.

Jan 13, 2017

Starship beams up Daimler for $17m seed round

Unmanned vehicle-based delivery service Starship Technologies has raised $17.2m in a seed round led by Daimler, a strategic partner since September.

Jan 13, 2017

Oxsonics resonates with series B investors

Oxford spinout Oxsonics and its sister company Orthoson have attracted $11.4m from backers including Oxford University.

Jan 12, 2017

Simon finds its way back to SmarterHQ

SmarterHQ has received $13m in a round featuring existing backer Simon Property Group that brought its financing to more than $33m since it was founded.

Jan 12, 2017

Jaguar Land Rover gets into CloudCar

The carmaker has paid $15m for a minority stake in CloudCar, and plans to use the company's automotive cloud services platform in its forthcoming electric model.

Jan 12, 2017

Satsuma spins out of SNBL with $12m

RA Capital Management and TPG Biotech provided the series A financing, as Shin Nippon Biomedical Laboratories spun out migraine treatment startup Satsuma Pharmaceuticals.

Jan 11, 2017

Cogito coaxes additional series B cash

The voice analysis software producer has added $4.1m to the $15m it raised in November from backers including Salesforce Ventures.

Jan 11, 2017

Cogito rethinks series B

MIT spinout Cogito has raised a $4m extension for its series B round, which achieved an initial $15m close in November 2016.

Jan 10, 2017

Sense tracks iRobot for $15m series A

Home energy monitor developer Sense has closed its Shell-backed series A round at $15m after iRobot's corporate venturing unit provided $1m.

Jan 10, 2017

Avidity makes precision funding move to raise $16m

Precision medicine company Avidity Biosciences has received $10m in equity funding and $6m in converted debt from backers including Takeda and EMS.

Jan 10, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here